News Daily News ¿Relaja el Acuerdo de la FDA con Amarin el Control de las Promociones Fuera de Indicación? Michael O'Riordan March 09, 2016
News Daily News Will FDA’s Settlement With Amarin Weaken Agency Oversight of Off-Label Promotion? Michael O'Riordan March 09, 2016
News Industry News Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study September 16, 2014
News Industry News Amarin Announces Publication of Case Study Results Describing Reductions in Multiple Lipid Parameters for Individual Hyperlipidemic Patients Switched to Vascepa(R) June 11, 2014